Skip to main content
ROSSARI BIOTECH LIMITED logo

ROSSARI BIOTECH LIMITED — Investor Relations & Filings

Ticker · ROSSARI ISIN · INE02A801020 LEI · 335800R7XFRR8ZTHBQ25 BSE.NS Manufacturing
Filings indexed 526 across all filing types
Latest filing 2025-07-25 Call Transcript
Country IN India
Listing BSE.NS ROSSARI

About ROSSARI BIOTECH LIMITED

https://www.rossari.com/

Rossari Biotech Limited is a specialty chemicals manufacturer focused on providing sustainable and innovative solutions across diverse sectors. The company operates through three primary business segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals, and Animal Health and Nutrition. In the HPPC segment, it supplies essential ingredients for detergents, soaps, paints, and water treatment applications. Its textile division offers a comprehensive range of chemicals for the entire textile value chain, including pre-treatment, dyeing, and finishing processes. Additionally, the company provides high-quality feed additives and supplements for the poultry and livestock industries. Driven by robust research and development capabilities, Rossari Biotech emphasizes eco-friendly chemistry and customized formulations to meet specific client requirements. With advanced manufacturing facilities, the company serves a global clientele, maintaining a strong focus on operational excellence.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call for Q1 FY26 held on July 21, 2025. It includes management's opening remarks, financial performance discussion, segment-wise analysis, CAPEX updates, and a Q&A session with analysts. The content is typical of a full earnings call transcript, providing comprehensive operational and financial commentary beyond just headline results. The presence of forward-looking statements, detailed segment performance, and Q&A confirms this is a Call Transcript (CT) rather than a brief Earnings Release (ER) or an Annual/Interim Report. The document length (15,000 characters) and detailed content further support this classification.
2025-07-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 85% confidence The document is a short notification letter addressed to stock exchanges regarding the availability of the audio recording of an earnings conference call for Q1 FY26. It references Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, which governs disclosures related to events such as earnings calls. The document does not contain any financial data or detailed transcript but merely informs about the recording's availability on the company's website. The length is only 1507 characters, which is quite short and fits the pattern of an announcement rather than the full transcript or report. Therefore, this document is best classified as a Call Transcript announcement or related notice. However, since it is not the transcript itself but an intimation about the audio recording, it aligns most closely with the Call Transcript (CT) category as it pertains to earnings call content disclosure.
2025-07-21 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release dated July 20, 2025, announcing the financial results for the quarter ended June 30, 2025 (Q1 FY26). It contains detailed financial performance data including revenues, EBITDA, PAT, EPS, and segment-wise performance. It also includes management commentary on the quarter's results and updates on capacity expansion projects. The document is not a full quarterly report with comprehensive financial statements but rather a summarized announcement of quarterly financial results. This matches the definition of an Earnings Release (ER), which is the initial announcement of quarterly/periodical financial results with key highlights only. The document length (8184 characters) and content confirm it is not merely an announcement of a report but the actual earnings release text. Therefore, the correct classification is ER with high confidence. Q1 2026
2025-07-20 English
Investor Presentation
Regulatory Filings
2025-07-20 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE Limited and National Stock Exchange of India Limited) regarding the publication of an extract of consolidated unaudited financial results for the quarter ended June 30, 2025. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulations 30 and 47, which pertain to disclosure and dissemination of financial results. The document mentions the extract of financial results being published in newspapers on July 20, 2025. The content is an announcement about the publication of financial results, not the full financial report itself. The document length is 15,000 characters, but the content is primarily a notification of publication rather than the full report or detailed financial data. Therefore, according to the "Menu vs Meal" rule, this is a Report Publication Announcement (RPA).
2025-07-20 English
ESOP/ESOS/ESPS
Regulatory Filings
2025-07-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.